VintaBio is a CDMO based in Philadelphia, Pennsylvania, that provides GMP-grade and research-grade services for the production of viral vectors, including AAV and lentiviral vectors. VintaBio provides their clients with customized process development and GMP manufacturing services for CGT therapies. Their traditional roadmap for clients includes research vector services, process development, analytical services, GMP production, and regulatory support. Additionally, VintaBio’s new 22,500-sq.-ft. production suites in Philadelphia were created specifically to facilitate efficient cell and gene therapy manufacturing.